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Abstract
Background: The aim of this study was to compare a gel-based test with the traditional direct agglutination test
(DAT) for the diagnosis of immune-mediated haemolytic anaemia (IMHA).
Methods: Canine (n = 247) and feline (n = 74) blood samples were submitted for DAT testing to two laboratories.
A subset of canine samples was categorized as having idiopathic IMHA, secondary IMHA, or no IMHA.
Results: The kappa values for agreement between the tests were in one laboratory 0.86 for canine and 0.58 for
feline samples, and in the other 0.48 for canine samples. The lower agreement in the second laboratory was
caused by a high number of positive canine DATs for which the gel test was negative. This group included
significantly more dogs with secondary IMHA.
Conclusions: The gel test might be used as a screening test for idiopathic IMHA and is less often positive in
secondary IMHA than the DAT.
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Background
Immune-mediated haemolytic anaemia (IMHA) is
caused by the binding of antibodies to the surface of red
blood cells (RBCs). The production of such antibodies
can be a primary autoimmune phenomenon or be asso-
ciated with underlying neoplasia, chronic infections,
inflammatory disease or be triggered by exposure to
drugs or vaccines (secondary IMHA) [1]. The criteria
used to define IMHA in dogs and cats vary between dif-
ferent studies; however, it is generally accepted that a
positive direct agglutination test (DAT), marked sphero-
cytosis or true autoagglutination are three hallmarks of
canine IMHA. At least one of these changes must be
present in a patient with haemolytic anaemia to warrant
a diagnosis of IMHA [2].
The DAT demonstrates the presence of anti-erythro-
cyte antibodies by incubating a suspension of washed
patient erythrocytes with polyvalent or monovalent
antisera specific for immunoglobulin or complement.
More recently, a gel-based test has been developed (Dia-
med, Cressier, Switzerland) [3]. The gel test is fast and
easy to perform and has the potential for in-house use.
A whole-blood sample may be used (instead of washed
and resuspended RBCs) and the test uses a smaller
blood volume than that required for the DAT [4].
The aims of this study were: (1) to perform a compar-
ison between the feline and canine gel test with the tra-
ditional DAT in a two-centre study, and (2) to assess
the usefulness of the gel test as a diagnostic tool in
IMHA in dogs. After completion of this investigation
the authors were notified by the manufacturers that
they were withdrawing this particular gel test from the
market. However, we believe it worthwhile to publish
the results of the study as it is possible that similar diag-
nostics based on this immunological principle may
become available in the future and help in standardizing
anti-erythrocyte antibody testing between laboratories.
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Methods
Study design and definition of sample material and
patients
The comparison of the gel test with the DAT was per-
formed on samples from referral patients and samples
sent by private practitioners for DAT testing submitted
to two centres, the Utrecht University Veterinary Diag-
nostic Laboratory (UVDL) and the Bristol Clinical
Immunology Diagnostic laboratory (BCIDL).
In the UVDL, 126 canine samples with a haematocrit
(Ht) below the lowest end of the reference range (0.42 l/
l) were included in the study (October 2008 - July 2009).
In the BCIDL, 74 feline (September 2007 - October
2009) and 121 canine samples (July 2007 - August 2008)
were included in the study without restriction on the
Ht. At the UVDL the experiments were approved by the
responsible ethical committee as required under Dutch
legislation. At the BCIDL all residual blood samples for
gel testing were used with permission of the animal
owner and in accordance with UK legislation.
Samples coming from private practitioners were sent
in by mail overnight. Both the gel test and the DAT
were performed within 24 hrs of receipt of the samples.
Until then samples were kept at 4°C.
The assessment of the usefulness of the gel test as a
diagnostic tool for IMHA was performed on cases from
the UVDL only. For this, all dogs that had either a posi-
tive gel test or DAT were categorized clinically as hav-
ing: (1) idiopathic IMHA, (2) secondary IMHA, or (3)
anaemia that was not immune-mediated (no IMHA).
The inclusion criteria for idiopathic IMHA were: (1)
acute onset anaemia due to haemolysis, (2) Ht below
0.35 l/l, (3) a positive DAT or spherocytosis. In cases
where an underlying disorder or recognized trigger fac-
tor (e.g. infection, neoplasia or administration of drugs)
was identified the dog was classified as having secondary
IMHA. In order to make this classification, information
available at the time of presentation as well as follow-up
and post-mortem results were reviewed.
Laboratory tests
Gel test
The gel test (Diamed, Cressier, Switzerland) was per-
formed according to the manufacturers’ instructions.
The test is presented in the form of a small plastic card
within which there are six columnar tubes with an over-
lying reservoir of wider diameter. The tube contains a
gel matrix impregnated with rabbit polyvalent DAT-
reagent specific for either dog or cat. The cards used by
the two centres were the same, but the UVDL was also
supplied with separate negative control cards that com-
prised tubes containing only the gel matrix without anti-
body. Using the diluent supplied by the manufacturer a
0.8% RBC suspension was prepared and 50 μl of this
suspension was pipetted into the reservoir above the gel.
In the BCIDL the patient RBC were first washed twice
in phosphate buffered saline (PBS; pH 7.4, 0.01 M) and
then resuspended in the diluent. The card was centri-
fuged in a purpose-designed centrifuge supplied by the
manufacturer that runs at a set centrifugal force for a
defined time period. Following centrifugation, the tubes
were examined to determine the distribution of the red
cells. In a negative test the cells were pelleted at the bot-
tom of the tube. Where cells were distributed within the
cell matrix the test result was recorded as weak positive.
Where cells were retained at the top of gel the test was
reported as positive.
DAT
In both laboratories a similar DAT protocol using was
used as described previously [5,6]. Erythrocytes from
each dog were washed three times in PBS and resus-
pended at 5% in PBS. All reagents were titrated in PBS
across the rows of a microtitre tray. An equal volume of
the 5% erythrocyte suspension was added to each well
and to control wells containing PBS alone. The microti-
tre trays were incubated until erythrocytes in the control
wells had settled. Agglutination was assessed visually,
and the titre was recorded as the reciprocal of the last
dilution of each antiserum giving a positive agglutination
reaction. The DAT was considered positive if at least
one of the reagents resulted in a positive titre and the
control wells showed no agglutination.
UVDL The test was performed with monovalent canine
Coombs’ reagents: rabbit anti-dog IgG (Fc), anti-dog
IgG (H+ L), and anti-dog IgM (Fc) antibodies (Nordic
Laboratories, the Netherlands). Tests with anti-IgG
reagents were performed at 37°C and tests with anti-
IgM at 4°C. A titre ≥ 16 was considered positive with
any antibody.
BCIDL The test was performed using a polyvalent
canine Coombs’ reagent (raised in rabbit) with specifi-
city for canine IgG, IgM and complement C3 (ICN
Pharmaceuticals, United Kingdom) and monovalent rab-
bit anti-dog IgG (Fc), rabbit anti-dog IgM (Fc) and goat
anti-dog C3 (Nordic Laboratories). All reagents were
pre-absorbed against a pool of normal canine erythro-
cytes. The test was performed in duplicate plates, one of
which was incubated at 4°C and the other at 37°C. A
titre ≥ 20 was considered positive.
The feline DAT was performed at both temperatures
with three species-specific antisera: polyvalent feline
Coombs’ reagent (ICN Pharmaceuticals, United King-
dom), rabbit anti-cat IgG (Fc) and rabbit anti-cat IgM
(Fc) (Nordic Laboratories) [7].
Haematology
UVDL The ADVIA 120 (Siemens Medical Solutions,
Diagnostics, USA) was used to determine Ht, total white
blood cell count (WBC), differential WBC counts,
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platelet count and reticulocyte count. All blood smears
were examined for the presence of spherocytes at the
time of this study by MWvL.
BCIDL Haematology results were available for samples
that had been submitted for concurrent haematological
examination and DAT testing. A Cell Dyn 3700 analyzer
(Abbot, USA) was used to determine Ht, WBC, differen-
tial WBC count, platelet and reticulocyte counts. These
analyses were performed by the Langford Veterinary
Services Diagnostic Laboratories.
Statistics
The results of the gel test were compared with the DAT
by plotting the log titres of the DAT against the gel test
results and determining correlation by ANOVA. Since
in the UVDL only samples with a Ht below the refer-
ence range were tested, we created for comparative pur-
poses a subset of 48 canine BCIDL samples with Ht
below the reference range used by the BCIDL (0.35 -
0.55 l/l). The percentage agreement between the gel test
and the DAT beyond chance, kappa, was calculated with
Win Episcope 2 http://www.clive.ed.ac.uk/winepiscope.
To test whether the kappa was significantly different
from 0, a one sided Z-test was used.
A comparison of the number of gel test and DAT out-
comes, pattern of reactivity, and the titre in the DAT for
dogs in the three clinical categories was made with Fish-
er’s exact test. All statistical analyses were performed in




Thirty two of the 126 UVDL dogs were classified as
having idiopathic IMHA, 31 as secondary IMHA, and
63 as no IMHA. The underlying disorders in the dogs
with secondary IMHA included neoplastic disease (six
haemopoietic tumours, one cutaneous mast cell tumour
and two abdominal masses), parasitic infections (one
Babesia canis and one Ehrlichia canis ), bacterial infec-
tions (two urogenital tract infections, two cases of bac-
terial lymphadenitis), immune-mediated disorders (two
idiopathic inflammatory bowel disease, one immune-
mediated thrombocytopenia, one systemic lupus erythe-
matosus, four pure red cell aplasia and three bone mar-
row dysplasia), central neurological disease (two dogs),
and in three dogs no definitive diagnosis was made.
Of the 32 dogs classified as having idiopathic IMHA,
20 animals were still alive at least 6 months after the
last sample was entered into the study. Eleven dogs died
due to IMHA within the first 2 weeks after diagnosis. In
these dogs extensive diagnostic testing did not reveal an
underlying disorder, nor did the post-mortem examina-
tion performed in two of these cases. All but six of the
dogs with idiopathic IMHA had a regenerative anaemia
at the time of diagnosis (corrected reticulocyte count ≥
1.5%; range 0.4 - 9.6%); one of these dogs died but the
other five developed a regenerative anaemia during the
first week of treatment.
Performance of the Gel Test versus the DAT
The log titres of the UVDL DAT were significantly asso-
ciated with a negative result in the gel test, versus the
combined weak positive and positive gel test results. For
the BCIDL data there was a significant association
between the log titres of the DAT and all three out-
comes of the gel test (data not shown). Kappa statistics
were performed using both the DAT and gel test results
as binary data. The comparative analysis of the two test
methods for canine samples for the two laboratories is
summarized in Table 1.
Pattern of Isotype Reactivity in DAT versus the Gel Test
Outcome
The pattern of antibody reactivity in the DAT in relation
to the gel test outcome is shown in Figures 1, 2 and 3.
Relation with Clinical Classification
The difference in distribution of the clinical outcome
over the DAT and gel test results was significantly dif-
ferent (P < 0.0001) (Figure 4). Of the 52 dogs negative
for both the gel test and the DAT, 51/52 (98%) did not
have IMHA. Only one of these dogs (2%) had idiopathic
IMHA. The gel test and the DAT in this dog were per-
formed one day after the start of immunosuppressive
treatment.
A prozone phenomenon was noted in 17 of the 126
UVDL canine samples. In all but one of these 17 sam-
ples the DAT titre was positive. In 5 of the 17 dogs
with prozones, the titre of the prozone was ≥ 16 (the
cut-off titre at which the UVDL DAT is regarded as
positive). Three of these five dogs had idiopathic IMHA
and two had secondary IMHA. Of the 17 dogs with pro-
zone effects, nine had idiopathic IMHA and the other
eight had secondary IMHA.
Table 1 Results of Gel test versus the DAT as performed
in the UVDL and BCIDL.









Ht < 0.35 l/l
- + Total - + Total - + Total - + Total
Negative 52 26 78 73 0 73 46 11 57 36 0 36
Positive 7 41 48 8 40 48 2 15 17 1 11 12
Total 59 67 126 81 40 121 48 26 74 37 11 48
Kappa 0.48* 0.86* 0.58* 0.94*
P < 0.0001; Tested against H0 that all observed agreement is based on chance
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The number of DAT reaction patterns in the dogs
with idiopathic IMHA was significantly different from
dogs with secondary IMHA (P < 0.0001) and no IMHA
(P < 0.0001), and also for the comparison of dogs with
secondary IMHA versus dogs without IMHA (P <
0.0001) (Table 2). Samples from dogs with idiopathic
IMHA more often achieved higher titres than those
from dogs with secondary IMHA, but this was not sta-
tistically significant (P = 0.34) (Table 3).
Discussion
The DAT is an accepted method of detection of anti-
erythrocyte antibodies and an essential part of the diag-
nosis of IMHA [2]. The first aim of this study was to
Figure 1 DAT antibody isotype reactivity pattern for 126 canine blood samples tested in the UVDL. Coombs’ test antibody isotype
reactivity pattern for 126 canine blood samples tested in the UVDL.
Figure 2 DAT antibody isotype reactivity pattern for 121 canine blood samples tested in the BCIDL.
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Figure 3 DAT antibody isotype reactivity pattern for 74 feline blood samples tested in the BCIDL.
Figure 4 Gel Test, DAT and spherocytosis in dogs with idiopathic IMHA, secondary IMHA and no IMHA.
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compare the results obtained in the DAT versus the gel
test. The high number of samples, 247 canine and 74
feline samples, creates a relatively powerful study, as for
such comparative investigations 40 samples has been
described as sufficient [8]. Analysis of the correlation
between the log titres of the DAT results and the ordi-
nal gel test results revealed that the latter can be inter-
preted as binary test results. Therefore kappa statistics
were chosen as the appropriate method to compare the
two tests in the absence of a “gold standard” for the
diagnosis of IMHA [8,9]. The kappa values for the com-
parison of the canine BCIDL (0.86) as well as the kappa
of 0.94 for the BCIDL canine samples with Ht below
0.35% can be interpreted as “almost perfect agreement”
and the kappa for the feline BCIDL samples (0.58) and
kappa for the UVLD canine samples (0.48) as “moderate
agreement” using the classification of Landis and Koch
[9].
The use of an extended DAT protocol such as per-
formed by both laboratories in this study in their diag-
nostic support for a university referral hospital has been
questioned for samples derived from first opinion clini-
cal practice [10]. A still unresolved issue is the use of
multiple dilutions of antisera to prevent false negative
DAT outcomes due to the prozone effect [5,11]. Five of
17 UVDL samples had prozones with a titre around the
cut-off value defined for the DAT and would have been
missed if higher dilutions of antiserum had not been
used.
A second issue concerns the inclusion of multiple
monovalent reagents to increase the sensitivity of the
DAT [5,12,13]. Indeed in the BCIDL canine samples, six
positive DATs would have been missed if the test had
relied on polyvalent antisera only. This finding corrobo-
rates a previous study by this laboratory in which 11 of
77 dogs with IMHA would have had a negative DAT
had the extended test protocol not been used [5].
The third issue related to the DAT is the clinical rele-
vance of performing an extended DAT with full deter-
mination of the pattern of antibody reactivity instead of
use of a polyvalent reagent only, such as in the gel test.
In human IMHA the antibody reactivity pattern is of
diagnostic relevance [14]. In dogs, however, the clinical
relevance remains debated. C3b and IgM reactivity have
been reported with higher frequency in secondary
IMHA [5,6] and IgM reactivity at 4°C was also more
often seen in the dogs with secondary IMHA in the pre-
sent study (Table 2). The clinical significance of cold
agglutinating antibodies is also widely debated. There is
a belief that they are less significant as they are rarely
active at body temperature [2], but few studies have
investigated the complete temperature gradient of the
reactivity of these immunoglobulins.
Despite the fact that the DAT is an accepted test for
the diagnosis of IMHA [2], it is by no means interna-
tionally standardized. To realise such standardisation
between laboratories will be very difficult, if not impos-
sible. A commercially produced test, such as the gel
test, might be better suited to this task. Therefore, in
addition to the comparative study of the two diagnostic
procedures, the second goal of the present study was to
investigate the value of the gel test as a diagnostic tool
Table 2 UVDL DAT reactivity patterns in dogs having idiopathic IMHA, secondary IMHA, and no IMHA.
IgG H+L 37°C IgG Fc 37°C IgM 4°C Idiopathic IMHA Secondary IMHA No IMHA
+ + - 20 7 1
+ - - 4 12 5
+ - + 0 4 0
+ + + 4 4 0
- + - 0 1 0
- + + 0 0 0
- - + 3 2 0
- - - 1 1 57
Total 32 31 63
Table 3 Number of dogs for each titre reached in the UVDL complete DAT for dogs having idiopathic IMHA,
secondary IMHA, and no IMHA.
Highest titre reached in the complete DAT
0 2 4 8 16 32 64 92 128 256 512 1024 2048 4096 Total
Idiopathic IMHA 1 0 0 0 5 3 2 0 4 7 1 0 3 6 32
Secondary IMHA 0 0 1 0 7 4 6 1 3 2 1 2 2 3 31
No IMHA 44 8 0 5 1 2 1 0 1 0 0 1 0 0 63
Total 45 8 1 5 13 9 9 1 8 9 2 3 5 9 126
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for IMHA. In the absence of a gold standard we defined
clinical categories of idiopathic IMHA, secondary IMHA
and no IMHA on the basis of a combination of diagnos-
tic criteria present at clinical presentation and as used
by others [2,15-20]. Additionally, these case definitions
included follow-up and pathology data in order to pre-
vent misclassification. It can be argued that this clinical
classification is based on subjective criteria; however,
until better methods have been found, it is consistent
with current clinical practice.
The gel test identified fewer positive samples than the
DAT despite the fact that in essence it is also a test reli-
ant on the use of a polyvalent antiserum (Figure 4). The
positive DAT samples that were missed by the gel test
(n = 27) were mainly from dogs with secondary IMHA
(n = 20). Only three cases of idiopathic IMHA were
missed. Since the gel test is faster and more easily per-
formed than the conventional DAT it might be used as
a screening test for IMHA, but if negative, IMHA can-
not be excluded and an extended DAT should be per-
formed. This observation contrasts, however, with the
findings in human samples where the micro-column gel
test is found to be more sensitive than the DAT [21,22].
Conclusions
Overall, in the present study there was a good agree-
ment between the results of the DAT and the gel test.
Additionally, the gel test performed well in identifying
dogs with idiopathic IMHA, but missed most of the
samples that were from dogs with secondary IMHA.
From a laboratory viewpoint these samples also differed
in having lower titres in the DAT, more frequent IgM
positivity and almost no spherocytosis.
The gel test offers an appealing option as an initial
screening test for idiopathic IMHA and a much-needed
means of standardizing anti-erythrocyte antibody testing.
It is therefore unfortunate that the current test has
recently been withdrawn from the market. It is entirely
feasible that the same or a similar diagnostic system
may be reintroduced in the future as often occurs in the
veterinary marketplace. The results of the present study
help validate a specific product, but equally may be used
to support the development and marketing of alternative
products based on the same immunological principle in
the future.
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